# Mylan II B.V.

Mylan II B.V. is a company headquartered in Hatfield, Hertfordshire, United Kingdom.

## Company overview

- **Legal name:** Mylan II B.V.
- **Former names in filing history:** Mylan N.V. (2015-02-27 to 2020-11-06); New Moon B.V. (2014-11-05 to 2014-12-24)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Hatfield, Hertfordshire, United Kingdom
- **Incorporated in:** P7
- **Fiscal year end:** December 31
- **SEC CIK:** 0001623613

## About

Mylan II B.V. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001623613, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2020-02-28, it reported annual revenue of USD 11,500,500,000; total assets of USD 31,255,500,000 for the fiscal period ended 2019-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2019 (period ended 2019-12-31)

- **Revenue:** $11.5B (USD 11,500,500,000)
- **Total assets:** $31.3B (USD 31,255,500,000)
- **Cash and equivalents:** $475.6M (USD 475,600,000)
- **Operating cash flow:** $1.8B (USD 1,803,700,000)

### FY2018 (period ended 2018-12-31)

- **Revenue:** $11.4B (USD 11,433,900,000)
- **Total assets:** $32.7B (USD 32,734,900,000)
- **Cash and equivalents:** $388.1M (USD 388,100,000)
- **Operating cash flow:** $2.3B (USD 2,341,700,000)

### FY2017 (period ended 2017-12-31)

- **Revenue:** $11.9B (USD 11,907,700,000)
- **Total assets:** $35.8B (USD 35,806,300,000)
- **Cash and equivalents:** $292.1M (USD 292,100,000)
- **Operating cash flow:** $2.1B (USD 2,064,800,000)

### FY2016 (period ended 2016-12-31)

- **Revenue:** $11.1B (USD 11,076,900,000)
- **Total assets:** $34.7B (USD 34,726,200,000)
- **Cash and equivalents:** $998.8M (USD 998,800,000)
- **Operating cash flow:** $2.0B (USD 2,047,200,000)

## Recent SEC filings

- Form S-4 — filed 2021-09-10 — FORM S-4
- Form 8-K — filed 2020-11-19 — period 2020-11-16 — 8-K
- Form 10-Q — filed 2020-11-06 — period 2020-09-30 — 10-Q
- Form 8-K — filed 2020-11-06 — period 2020-11-06 — 8-K
- Form 8-K — filed 2020-09-11 — period 2020-09-07 — 8-K
- Form 10-Q — filed 2020-08-06 — period 2020-06-30 — 10-Q
- Form 8-K — filed 2020-08-06 — period 2020-08-06 — 8-K
- Form 8-K — filed 2020-07-02 — period 2020-06-30 — FORM 8-K
- Form 8-K — filed 2020-06-19 — period 2020-06-19 — FORM 8-K
- Form 8-K — filed 2020-06-17 — period 2020-06-16 — 8-K
- Form 8-K — filed 2020-06-12 — period 2020-06-12 — 8-K
- Form DEF 14A — filed 2020-06-08 — period 2020-06-30 — DEF 14A

---

Updated: 2026-10-23T20:06:36Z

Canonical page: https://altss.com/profile/mylan-ii-b-v

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology